Particle.news
Download on the App Store

Oprah Winfrey Releases 'Enough,' Detailing GLP-1 Use and a Shift in the Obesity Conversation

Her book and fresh TV interviews present obesity as a chronic disease and describe the medications as a long-term tool that quieted persistent food thoughts.

Overview

  • The new book, coauthored with Yale obesity specialist Dr. Ania M. Jastreboff, argues obesity is a relapsing biological condition rather than a willpower failure.
  • Winfrey told Today she experienced constipation on a GLP-1 and manages it with water and magnesium, as her coauthor advised slow dose increases to reduce side effects.
  • She said the intrusive “food noise” subsided within hours of her first dose and that she now treats the medication as one tool alongside daily hikes, resistance training, and diet.
  • Winfrey disclosed she regained about 20 pounds after stopping the drug for a year, informing her decision to maintain therapy over time.
  • A new conversation with Serena Williams highlights changing attitudes, as Williams describes initial skepticism about “shortcuts” before publicly supporting GLP-1 use and partnering with telehealth firm Ro.